Health Care & Life Sciences » Biotechnology | GlycoMimetics Inc.

GlycoMimetics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,393.60
55,256.60
46,802.60
40,041.60
123,924.70
209,917.60
Total Accounts Receivable
-
22.30
38.70
268.70
102.00
413.10
Other Current Assets
2,490.10
836.20
403.10
209.80
3,192.90
1,938.40
Total Current Assets
4,883.70
56,115.20
47,244.40
40,520.10
127,219.60
212,269.10
Net Property, Plant & Equipment
399.80
452.30
521.40
1,056.30
1,106.90
957.20
Other Assets
-
696.50
696.50
811.90
256.70
1,612.90
Total Assets
5,283.50
57,264.00
48,462.30
42,388.30
128,583.20
214,839.30
Accounts Payable
1,144.90
874.00
564.20
-
2,647.10
Other Current Liabilities
1,134.40
5,586.50
7,182.70
6,333.60
5,527.70
Total Current Liabilities
2,279.30
6,460.50
7,747.00
6,333.60
8,174.80
Other Liabilities
96.80
-
243.70
753.60
707.00
Total Liabilities
2,376.10
6,460.50
7,990.60
7,087.20
8,881.80
Common Equity (Total)
2,876.70
50,803.40
40,471.70
35,301.10
119,701.40
Total Shareholders' Equity
2,907.40
50,803.40
40,471.70
35,301.10
119,701.40
Total Equity
2,907.40
50,803.40
40,471.70
35,301.10
119,701.40
Liabilities & Shareholders' Equity
5,283.50
57,264.00
48,462.30
42,388.30
128,583.20
Preferred Stock (Carrying Value)
30.70
-
-
-
-

About GlycoMimetics

View Profile
Address
9708 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.glycomimetics.com
Updated 07/08/2019
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K.